Management of Minimally Invasive Spine Surgery in Spinal Metastases: A Comprehensive Systematic Review and Meta-Analysis on Strategies, Treatments, and Outcomes
Abstract
Background: Minimally invasive spine surgery (MISS) represents an effective and increasingly adopted treatment strategy for spinal metastases. Over one million Americans are diagnosed with spinal metastases each year, and just 1.5 million are reported to be diagnosed; only 40-70 percent are spinal metastases. More advanced current percutaneous treatments such as kyphoplasty and vertebroplasty have improved the status of patients previously ruled out for surgery. Osteoblastic and osteolytic spinal metastases can be assessed and treated with percutaneous microwave ablation.
Methods: A systematic review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The comprehensive search involved several databases, including ScienceDirect and PubMed/MEDLINE, and was performed using the PRISMA guidelines, R software, and Excel. Search terms included “minimally invasive approach in metastatic lesions of the spine and spinal cord” combined with terms specifying surgical techniques, rehabilitation methods, and associated pathologies. Only studies published in English from January 2012 to February 2025 were included.
Results: Our study was based on a comprehensive systematic review and meta-analysis of 2380 patients with spinal metastases who were treated with minimally invasive and traditional open approaches, specifically vertebroplasty and kyphoplasty. We found 1090 patients (46%) with spinal metastases, where 509 cases (21%) were treated with the minimally invasive approach (MISS), while the traditional open approach [traditional open surgery (TOS)] was used for 432 patients (18%). 1611 patients (67%) were intervened by the leves of the fractures. Affected levels, whose cement breaches were 752 patients (31%) with metastases and CSF leaking.
Conclusion: New concepts were also employed in the minimally invasive, open approach which began with minimally invasive procedures such as vertebroplasty and kyphoplasty, and proceeded to treatments like percutaneous microwave ablation. Simple radiation therapy and chemotherapy, including the use of second-generation bisphosphonates such as pamidronate, are recommended, as well as steroids such as dexamethasone and methylprednisolone.
2. Pennington Z, Ahmed AK, Molina CA, Ehresman J, Laufer I, Sciubba DM. Minimally invasive versus conventional spine surgery for vertebral metastases: a systematic review of the evidence. Ann Transl Med. 2018;6(6):103. doi: 10.21037/atm.2018.01.28. [PubMed: 29707552]. [PubMed Central: PMC5900071].
3. Hariri O, Takayanagi A, Miulli DE, Siddiqi J, Vrionis F. Minimally Invasive Surgical Techniques for Management of Painful Metastatic and Primary Spinal Tumors. Cureus.
2017;9(3):e1114. doi: 10.7759/cureus.1114. [PubMed: 28446993].
[PubMed Central: PMC5403161].
4. Yang T, Ke J, Cheng S, He Y, Huang W, Yao M, et al. Clinical
guidelines for microwave ablation of spinal metastases. J Cancer Res Ther. 2022;18(7):1845-54. doi: 10.4103/jcrt.jcrt_655_22. [PubMed: 36647941].
5. Guarnieri G, Izzo R, Muto M. Current trends in mini-invasive management of spine metastases. Interv Neuroradiol. 2015;21(2):263-72. doi: 10.1177/1591019915582366. [PubMed: 25964441]. [PubMed Central: PMC4757234].
6. Kato S, Demura S, Shinmura K, Yokogawa N, Shimizu T, Murakami H, et al. Surgical Metastasectomy in the Spine: A Review Article. Oncologist. 2021;26(10):e1833-e43. doi: 10.1002/onco.13840. [PubMed: 34076920]. [PubMed Central: PMC8488775].
7. Zhu X, Lu J, Xu H, Tang Q, Song G, Deng C, et al. A Comparative Study Between Minimally Invasive Spine Surgery and Traditional Open Surgery for Patients With Spinal Metastasis. Spine (Phila Pa 1976). 2021;46(1):62-8. doi: 10.1097/brs.0000000000003690. [PubMed: 32925689].
8. Saadeh YS, Elswick CM, Fateh JA, Smith BW, Joseph JR, Spratt DE, et al. Analysis of Outcomes Between Traditional Open versus Mini-Open Approach in Surgical Treatment of Spinal Metastasis. World Neurosurg. 2019;130:e467-e74. doi: 10.1016/j.wneu.2019.06.121. [PubMed: 31247354].
9. Morgen SS, Hansen LV, Karbo T, Svardal-Stelmer R, Gehrchen M, Dahl B. Minimal Access vs. Open Spine Surgery in Patients With Metastatic Spinal Cord Compression - A One-Center Randomized Controlled Trial. Anticancer Res. 2020;40(10):5673-8. doi: 10.21873/anticanres.114581. [PubMed: 32988892].
10. Hansen-Algenstaedt N, Kwan MK, Algenstaedt P, Chiu CK, Viezens L, Chan TS, et al. Comparison Between Minimally Invasive Surgery and Conventional Open Surgery for Patients With Spinal Metastasis: A Prospective Propensity Score- Matched Study. Spine (Phila Pa 1976). 2017;42(10):789-97. doi: 10.1097/brs.0000000000001893. [PubMed: 27584676].
11. Hikata T, Isogai N, Shiono Y, Funao H, Okada E, Fujita N, et al. A Retrospective Cohort Study Comparing the Safety and Efficacy of Minimally Invasive Versus Open Surgical Techniques in the Treatment of Spinal Metastases. Clin Spine Surg. 2017;30(8): E1082-e7. doi: 10.1097/bsd.0000000000000460. [PubMed: 27841799].
12. Kumar N, Malhotra R, Maharajan K, Zaw AS, Wu PH, Makandura MC, et al. Metastatic Spine Tumor Surgery: A Comparative Study of Minimally Invasive Approach Using Percutaneous Pedicle Screws Fixation Versus Open Approach. Clin Spine Surg. 2017;30(8):E1015-e21. doi: 10.1097/bsd.0000000000000400. [PubMed: 27352374].
13. Fang T, Dong J, Zhou X, McGuire RA, Jr., Li X. Comparison of mini-open anterior corpectomy and posterior total en bloc spondylectomy for solitary metastases of the thoracolumbar spine. J Neurosurg Spine. 2012;17(4):271-9. doi: 10.3171/2012.7.Spine111086. [PubMed: 22881038].
14. Miscusi M, Polli FM, Forcato S, Ricciardi L, Frati A, Cimatti M, et al. Comparison of minimally invasive surgery with standard open surgery for vertebral thoracic metastases causing acute myelopathy in patients with short- or mid-term life expectancy: surgical technique and early clinical results. J Neurosurg Spine. 2015;22(5):518-25. doi: 10.3171/2014.10.Spine131201. [PubMed: 25723122].
15. Lau D, Chou D. Posterior thoracic corpectomy with cage reconstruction for metastatic spinal tumors: comparing the mini-open approach to the open approach. J Neurosurg Spine. 2015;23(2):217-27. doi: 10.3171/2014.12.Spine14543. [PubMed: 25932599].
16. Huang TJ, Hsu RW, Li YY, Cheng CC. Minimal access spinal surgery (MASS) in treating thoracic spine metastasis. Spine (Phila Pa 1976). 2006;31(16):1860-3. doi: 10.1097/01.brs.0000225995.56028.46. [PubMed: 16845365].
17. Quraishi NA, Rajagopal TS, Manoharan SR, Elsayed S, Edwards KL, Boszczyk BM. Effect of timing of surgery on neurological outcome and survival in metastatic spinal cord compression. Eur Spine J. 2013;22(6):1383-8. doi: 10.1007/s00586-012-2635-y. [PubMed: 23275041]. [PubMed Central: PMC3676569].
18. Lo WY, Yang SH. Metastatic spinal cord compression (MSCC) treated with palliative decompression: Surgical timing and survival rate. PLoS One. 2017;12(12):e0190342. doi: 10.1371/journal.pone.0190342. [PubMed: 29287117]. [PubMed Central: PMC5747484].
19. Fan Y, Zhou X, Wang H, Jiang P, Cai S, Zhang J, et al. The timing of surgical intervention in the treatment of complete motor paralysis in patients with spinal metastasis. Eur Spine J. 2016;25(12):4060-6. doi: 10.1007/s00586-016-4406-7. [PubMed: 26831534].
20. Meyer HS, Wagner A, Raufer A, Joerger AK, Gempt J, Meyer B. Surgery in Acute Metastatic Spinal Cord Compression: Timing and Functional Outcome. Cancers (Basel). 2022;14(9):2249. doi: 10.3390/cancers14092249. [PubMed: 35565376]. [PubMed Central: PMC9099617].
21. Younsi A, Riemann L, Scherer M, Unterberg A, Zweckberger K. Impact of decompressive laminectomy on the functional outcome of patients with metastatic spinal cord compression and neurological impairment. Clin Exp Metastasis. 2020;37(2):377-90. doi: 10.1007/s10585-019-10016-z. [PubMed: 31960230]. [PubMed Central: PMC7138774].
22. Tateiwa D, Oshima K, Nakai T, Imura Y, Tanaka T, Outani H, et al. Clinical outcomes and significant factors in the survival rate after decompression surgery for patients who were non- ambulatory due to spinal metastases. J Orthop Sci. 2019;24(2):347-52. doi: 10.1016/j.jos.2018.10.003. [PubMed: 30482604].
23. Colangeli S, Capanna R, Bandiera S, Ghermandi R, Girolami M, Parchi PD, et al. Is minimally-invasive spinal surgery a reliable treatment option in symptomatic spinal metastasis? Eur Rev Med Pharmacol Sci. 2020;24(12):6526-32. doi: 10.26355/eurrev_202006_21636. [PubMed: 32633339].
24. Santipas B, Ruangchainikom M, Wilartratsami S, Jiamamornrat S, Panatreswas N, Luksanapruksa P. Safety and feasibility of ultra-long construct navigated minimally invasive spine surgery with adjuvant radiotherapy in extensive spinal metastasis : a comparative analysis. BMC Cancer. 2023;23(1):1246. doi: 10.1186/s12885-023-11729-x. [PubMed: 38110860]. [PubMed Central: PMC10726526].
25. Encarnación-Santos D, Chmutin G, Bozkurt I, Chaurasia B, Umana GE, Nicoletti GF, et al. Letter to the Editor Regarding "Minimally Invasive Spine Surgery: An Overview". World Neurosurg. 2024;184:353-4. doi: 10.1016/j.wneu.2023.11.141. [PubMed: 38590064].
26. Poullay Silven M, Encarnación-Santos D, Volovish A, Nicoletti GF, Iacopino DG, Valerievich KA. Letter to the Editor Regarding "Minimally Invasive Surgery for Spinal Metastasis: A Review". World Neurosurg. 2024;184:358-9. doi: 10.1016/j.wneu.2023.12.046. [PubMed: 38590068].
27. Wang L, Zhang C, Liang H, Huang T, Zhong W, Zhao Z, et al. Cement leakage in percutaneous vertebroplasty for spinal metastases: a retrospective study of risk factors and clinical outcomes. World J Surg Oncol. 2022;20(1):112. doi: 10.1186/s12957-022-02583-5. [PubMed: 35387653]. [PubMed Central: PMC8988338].
28. Ragheb A, Vanood A, Fahim DK. The Addition of Radiofrequency Tumor Ablation to Kyphoplasty May Reduce the Rate of Local Recurrence in Spinal Metastases Secondary to Breast Cancer. World Neurosurg. 2022;161:e500-e7. doi: 10.1016/j.wneu.2022.02.052. [PubMed: 35183797].
29. Cui Y, Pan Y, Lin Y, Mi C, Wang B, Shi X. Risk factors for predicting cement leakage in percutaneous vertebroplasty for spinal metastases. J Orthop Sci. 2022;27(1):79-83. doi: 10.1016/j.jos.2020.10.004. [PubMed: 33158733].
30. Shi X, Cui Y, Pan Y, Wang B, Lei M. Epidemiology and detection of cement leakage in patients with spine metastases treated with percutaneous vertebroplasty: A 10-year observational study. J Bone Oncol. 2021;28:100365. doi: 10.1016/j.jbo.2021.100365. [PubMed: 34026477]. [PubMed Central: PMC8134071].
31. Yan BC, Fan YF, Tian QH, Wang T, Huang ZL, Song HM, et al. Efficacy and Safety of the Safe Triangular Working Zone Approach in Percutaneous Vertebroplasty for Spinal Metastasis. Korean J Radiol. 2022;23(9):901-10. doi: 10.3348/kjr.2021.0914. [PubMed: 35926840]. [PubMed Central: PMC9434739].
32. Xia Y, Zhai H, Wang X, Wang Y, Feng B. Combined Percutaneous Kyphoplasty/Pediculoplasty by Posterolateral Transpedicular Approach for Painful Cervical Spine Metastases: A Single-Center Prospective Study. J Pain Res. 2021;14:1699-706. doi: 10.2147/jpr.S310446. [PubMed: 34140806]. [PubMed Central: PMC8203187].
33. Tekin SB, Karslı B, Büyükbebeci O, Demir İ H, Gökalp AY, Kılınçoğlu V. How do vertebroplasty and kyphoplasty affect the quality of life of patients with multiple myeloma spinal metastasis? Eur J Orthop Surg Traumatol. 2020;30(8):1447-51. doi: 10.1007/s00590-020-02721-3. [PubMed: 32591912].
34. Sebaaly A, Najjar A, Wang Z, Boubez G, Masucci L, Shedid D. Anterolateral Cervical Kyphoplasty for Metastatic Cervical Spine Lesions. Asian Spine J. 2018;12(5):823-9. doi: 10.31616/asj.2018.12.5.823. [PubMed: 30213164]. [PubMed Central: PMC6147870].
35. He S, Zhou Z, Zhang C, Lv N, Qian Z, Sun Z. Kyphoplasty in the treatment of occult and non-occult metastatic vertebral tumors. Medicine (Baltimore). 2020;99(25):e20430. doi: 10.1097/md.0000000000020430. [PubMed: 32569166]. [PubMed Central: PMC7310909].
36. Stangenberg M, Viezens L, Eicker SO, Mohme M, Mende KC, Dreimann M. Cervical vertebroplasty for osteolytic metastases as a minimally invasive therapeutic option in oncological surgery: outcome in 14 cases. Neurosurg Focus. 2017;43(2):E3. doi: 10.3171/2017.5.Focus17175. [PubMed: 28760030].
37. Sun G, Li L, Jin P, Liu XW, Li M. Percutaneous vertebroplasty for painful spinal metastasis with epidural encroachment. J Surg Oncol. 2014;110(2):123-8. doi: 10.1002/jso.23608. [PubMed: 24665071].
38. Zhang HT, Chen GD, Yang HL, Luo ZP. Percutaneous Kyphoplasty in the Treatment of Osteoblastic-related Spinal Metastases. Clin Spine Surg. 2017;30(2):80-4. doi: 10.1097/BSD.0b013e3182a35745. [PubMed: 28207616].
39. Bao L, Jia P, Li J, Chen H, Dong Y, Feng F, et al. Percutaneous Vertebroplasty Relieves Pain in Cervical Spine Metastases. Pain Res Manag. 2017;2017:3926318. doi: 10.1155/2017/3926318. [PubMed: 28239257]. [PubMed Central: PMC5292401].
40. Liu H, Wang S, Liu T, Meng B, He F, Zhou R, et al. Incremental temperature cement delivery technique may prevent cement leakage in metastatic vertebral lesions. J Orthop Surg (Hong Kong). 2017;25(3):2309499017718931. doi: 10.1177/2309499017718931. [PubMed: 29141521].
41. Molloy S, Sewell MD, Platinum J, Patel A, Selvadurai S, Hargunani R, et al. Is balloon kyphoplasty safe and effective for cancer-related vertebral compression fractures with posterior vertebral body wall defects? J Surg Oncol. 2016;113(7):835-42. doi: 10.1002/jso.24222. [PubMed: 26996273].
42. Encarnacion D, Chmutin GE, Bozkurt I, Wellington J, Geraldino EB, Chaurasia B. Lesions of the spinal cord caused by multiple myeloma: A systematic review and meta-analysis regarding the neurosurgical aspects of patient management. J Craniovertebr Junction Spine. 2023;14(4):313-8. doi: 10.4103/jcvjs.jcvjs_111_23. [PubMed: 38268680]. [PubMed Central: PMC10805160].
43. Encarnacion-Santos D, Nurmukhametov R, Bozkurt I, Dosanov M, Volovish A, Chaurasia B. Restoring vertebral height in the treatment of multilevel vertebral compression fractures with vertebroplasty. Egypt J Neurol Psychiatry Neurosurg. 2023;59:135. doi: 10.1186/s41983-023-00737-0.
44. Encarnacion-Santos D, Chmutin G, Abdurakhmonov S, Bozkurt I, Geraldino EB, Prakash S, et al. Current Concepts, Management, and Outcomes of Traumatic Spinal Cord Injury: A Systematic Review and Meta-analysis. Int J Res Orthop surg. 2024;32(2):71-82. doi: 10.4103/ijors.ijors_17_24.
45. Choi D, Crockard A, Bunger C, Harms J, Kawahara N, Mazel C, et al. Review of metastatic spine tumour classification and indications for surgery: the consensus statement of the Global Spine Tumour Study Group. Eur Spine J. 2010;19(2):215-22. doi: 10.1007/s00586-009-1252-x. [PubMed: 20039084]. [PubMed Central: PMC2899817].
46. Boriani S, Weinstein JN, Biagini R. Primary bone tumors of the spine. Terminology and surgical staging. Spine (Phila Pa 1976). 1997;22(9):1036-44. doi: 10.1097/00007632-199705010-00020. [PubMed: 9152458].
47. Tokuhashi Y, Kawano H, Ohsaka S, Matsuzaki H, Toriyama S. [A scoring system for preoperative evaluation of the prognosis ofmetastatic spine tumor (a preliminary report)]. Nihon Seikeigeka Gakkai Zasshi. 1989;63(5):482-9. [PubMed: 2794626].
48. Tokuhashi Y, Matsuzaki H, Kawano H, Sano S. [The indication of operative procedure for a metastatic spine tumor: a scoring system for the preoperative evaluation of the prognosis]. Nihon Seikeigeka Gakkai Zasshi. 1994;68(5):379-89. [PubMed: 8051465].
49. Tokuhashi Y, Matsuzaki H, Oda H, Oshima M, Ryu J. A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine (Phila Pa 1976). 2005;30(19):2186-91. doi: 10.1097/01.brs.0000180401.06919.a5. [PubMed: 16205345].
50. Tokuhashi Y, Ajiro Y, Umezawa N. Outcome of treatment for spinal metastases using scoring system for preoperative evaluation of prognosis. Spine (Phila Pa 1976). 2009;34(1):69-73. doi: 10.1097/BRS.0b013e3181913f19. [PubMed: 19127163].
51. Karnofsky DA. Clinical evaluation of anticancer drugs: cancer chemotherapy. Gann Monogr. 1967;2:223-31.
52. Tokuhashi Y, Uei H, Oshima M, Ajiro Y. Scoring system for prediction of metastatic spine tumor prognosis. World J Orthop. 2014;5(3):262-71. doi: 10.5312/wjo.v5.i3.262. [PubMed: 25035829]. [PubMed Central: PMC4095019].
53. Bauer HC, Wedin R. Survival after surgery for spinal and extremity metastases. Prognostication in 241 patients. Acta Orthop Scand. 1995;66(2):143-6. doi: 10.3109/17453679508995508. [PubMed: 7740944].
54. Leithner A, Radl R, Gruber G, Hochegger M, Leithner K, Welkerling H, et al. Predictive value of seven preoperative prognostic scoring systems for spinal metastases. Eur Spine J. 2008;17(11):1488-95. doi: 10.1007/s00586-008-0763-1. [PubMed: 18787846]. [PubMed Central: PMC2583181].
55. Hibberd CS, Quan GMY. Accuracy of Preoperative Scoring Systems for the Prognostication and Treatment of Patients with Spinal Metastases. Int Sch Res Notices. 2017;2017:1320684. doi: 10.1155/2017/1320684. [PubMed: 28894788]. [PubMed Central: PMC5574303].
56. Klimo P, Jr., Schmidt MH. Surgical management of spinal metastases. Oncologist. 2004;9(2):188-96. doi: 10.1634/theoncologist.9-2-188. [PubMed: 15047923].
57. Yamada Y, Lovelock DM, Yenice KM, Bilsky MH, Hunt MA, Zatcky J, et al. Multifractionated image-guided and stereotactic intensity-modulated radiotherapy of paraspinal tumors: a preliminary report. Int J Radiat Oncol Biol Phys. 2005;62(1):53-61. doi: 10.1016/j.ijrobp.2004.09.006. [PubMed: 15850902].
58. Rades D, Fehlauer F, Stalpers LJ, Wildfang I, Zschenker O, Schild SE, et al. A prospective evaluation of two radiotherapy schedules with 10 versus 20 fractions for the treatment of metastatic spinal cord compression: final results of a multicenter study. Cancer. 2004;101(11):2687-92. doi: 10.1002/cncr.20633. [PubMed: 15493037].
59. Joaquim A, Powers A, Laufer I, Bilsky M. An update in the management of spinal metastases. Arq Neuropsiquiatr. 2015;73(9):795-802. doi: 10.1590/0004-282X20150099. [PubMed: 26352500].
60. Igoumenou VG, Mavrogenis AF, Angelini A, Baracco R, Benzakour A, Benzakour T, et al. Complications of spine surgery for metastasis. Eur J Orthop Surg Traumatol. 2020;30(1):37-56. doi: 10.1007/s00590-019-02541-0. [PubMed: 31473821].
61. Quraishi NA, Gokaslan ZL, Boriani S. The surgical management of metastatic epidural compression of the spinal cord. J Bone Joint Surg Br. 2010;92(8):1054-60. doi: 10.1302/0301- 620x.92b8.22296. [PubMed: 20675746].
62. Vazifehdan F, Karantzoulis VG, Igoumenou VG. Surgical treatment for metastases of the cervical spine. Eur J Orthop Surg Traumatol. 2017;27(6):763-75. doi: 10.1007/s00590-017-2002- 0. [PubMed: 28638950].
63. Mavrogenis AF, Pneumaticos S, Sapkas GS, Papagelopoulos PJ. Metastatic epidural spinal cord compression. Orthopedics. 2009;32(6):431-9; quiz 40-1. doi: 10.3928/01477447-20090511-20. [PubMed: 19634817].
64. Constans JP, de Divitiis E, Donzelli R, Spaziante R, Meder JF, Haye C. Spinal metastases with neurological manifestations. Review of 600 cases. J Neurosurg. 1983;59(1):111-8. doi: 10.3171/jns.1983.59.1.0111. [PubMed: 6864265].
65. Perrin RG, Laxton AW. Metastatic spine disease: epidemiology, pathophysiology, and evaluation of patients. Neurosurg Clin N Am. 2004;15(4):365-73. doi: 10.1016/j.nec.2004.04.018. [PubMed: 15450871].
66. Salvo N, Christakis M, Rubenstein J, de Sa E, Napolskikh J, Sinclair E, et al. The role of plain radiographs in management of bone metastases. J Palliat Med. 2009;12(2):195-8. doi: 10.1089/jpm.2008.0055. [PubMed: 19207068].
67. Hamaoka T, Madewell JE, Podoloff DA, Hortobagyi GN, Ueno NT. Bone imaging in metastatic breast cancer. J Clin Oncol. 2004;22(14):2942-53. doi: 10.1200/jco.2004.08.181. [PubMed: 15254062].
68. Yang HL, Liu T, Wang XM, Xu Y, Deng SM. Diagnosis of bone metastases: a meta-analysis comparing 18FDG PET, CT, MRI and bone scintigraphy. Eur Radiol. 2011;21(12):2604-17. doi: 10.1007/s00330-011-2221-4. [PubMed: 21887484].
69. Jehn CF, Diel IJ, Overkamp F, Kurth A, Schaefer R, Miller K, et al. Management of Metastatic Bone Disease Algorithms for Diagnostics and Treatment. Anticancer Res. 2016;36(6):2631-7. [PubMed: 27272771].
70. Peterson JJ, Kransdorf MJ, O'Connor MI. Diagnosis of occult bone metastases: positron emission tomography. Clin Orthop Relat Res. 2003(415 Suppl):S120-8. doi: 10.1097/01.blo.0000093051.96273.7c. [PubMed: 14600601].
71. Chakraborty D, Bhattacharya A, Mete UK, Mittal BR. Comparison of 18F fluoride PET/CT and 99mTc-MDP bone scan in the detection of skeletal metastases in urinary bladder carcinoma. Clin Nucl Med. 2013;38(8):616-21. doi: 10.1097/RLU.0b013e31828da5cc. [PubMed: 23603596].
72. Tsukamoto S, Kido A, Tanaka Y, Facchini G, Peta G, Rossi G, et al. Current Overview of Treatment for Metastatic Bone Disease. Curr Oncol. 2021;28(5):3347-72. doi: 10.3390/curroncol28050290. [PubMed: 34590591]. [PubMed Central: PMC8482272].
73. Vasudeva VS, Ropper AE, Rodriguez S, Wu KC, Chi JH. Contralateral osteotomy of the pedicle and posterolateral elements for en bloc resection: a technique for oncological resection of posterolateral spinal tumors. J Neurosurg Spine. 2017;26(3):275-81. doi: 10.3171/2016.8.Spine16398. [PubMed: 27791830].
74. Morimoto T, Toda Y, Hakozaki M, Paholpak P, Watanabe K, Kato K, et al. A new era in the management of spinal metastasis. Front Oncol. 2024;14:1374915. doi: 10.3389/fonc.2024.1374915. [PubMed: 38694784]. [PubMed Central: PMC11062132].
75. Winking M, Stahl JP, Oertel M, Schnettler R, Böker DK. PMMA vertebroplasty in patients with malignant vertebral destruction of the thoracic and lumbar spine. Ger Med Sci. 2003;1:Doc08. [PubMed: 19675706]. [PubMed Central: PMC2703227].
76. Zhang HR, Xu MY, Yang XG, Qiao RQ, Li JK, Hu YC. Percutaneous vertebral augmentation procedures in the management of spinal metastases. Cancer Lett. 2020;475:136-42. doi: 10.1016/j.canlet.2020.01.038. [PubMed: 32032679].
77. Sajan A, Isaacson A, Bagla S. Interventional Management of Painful Vertebral Body Metastases. Semin Intervent Radiol. 2022;39(2):172-5. doi: 10.1055/s-0042-1745719. [PubMed: 35781995]. [PubMed Central: PMC9246494].
78. Giammalva GR, Costanzo R, Paolini F, Benigno UE, Porzio M, Brunasso L, et al. Management of Spinal Bone Metastases With Radiofrequency Ablation, Vertebral Reinforcement and Transpedicular Fixation: A Retrospective Single-Center Case Series. Front Oncol. 2021;11:818760. doi: 10.3389/fonc.2021.818760. [PubMed: 35127531]. [PubMed Central: PMC8814334].
79. Wallace AN, Greenwood TJ, Jennings JW. Use of Imaging in the Management of Metastatic Spine Disease With Percutaneous Ablation and Vertebral Augmentation. AJR Am J Roentgenol. 2015;205(2):434-41. doi: 10.2214/ajr.14.14199. [PubMed: 26204297].
80. Elnoamany H. Percutaneous Selective Vertebroplasty: State of the Art Management in Well-Confined Metastatic Vertebral Lesions. Asian Spine J. 2016;10(5):869-76. doi: 10.4184/asj.2016.10.5.869. [PubMed: 27790314]. [PubMed Central: PMC5081321].
81. Barragán-Campos HM, Le Faou AL, Rose M, Livartowski A, Doz M, Astagneau P, et al. Percutaneous vertebroplasty in vertebral metastases from breast cancer: interest in terms of pain reliefand quality of life. Interv Neuroradiol. 2014;20(5):591-602. doi: 10.15274/inr-2014-10084. [PubMed: 25363262]. [PubMed Central: PMC4243229].
82. Afathi M, Mansouri N, Farah K, Benichoux V, Blondel B, Fuentes S. Use of Cement-Augmented Percutaneous Pedicular Screws in the Management of Multifocal Tumoral Spinal Fractures. Asian Spine J. 2019;13(2):305-12. doi: 10.31616/asj.2018.0129. [PubMed: 30481979]. [PubMed Central: PMC6454290].
83. Faiella E, Vaccarino F, Pacella G, Santucci D, Vergantino E, Bruno A, et al. Exploring the Efficacy of Combining Radiofrequency Thermal Ablation or Microwave Ablation with Vertebroplasty for Pain Control and Disease Management in Metastatic Bone Disease-A Systematic Review. Curr Oncol. 2024;31(9):5422-38. doi: 10.3390/curroncol31090401. [PubMed: 39330029]. [PubMed Central: PMC11430811].
84. David E, Kaduri S, Yee A, Chow E, Sahgal A, Chan S, et al. Initial single center experience: radiofrequency ablation assisted vertebroplasty and osteoplasty using a bipolar device in the palliation of bone metastases. Ann Palliat Med. 2017;6(2):118-24. doi: 10.21037/apm.2016.12.02. [PubMed: 28249543].
85. Laufer I, Sciubba DM, Madera M, Bydon A, Witham TJ, Gokaslan ZL, et al. Surgical management of metastatic spinal tumors. Cancer Control. 2012;19(2):122-8. doi: 10.1177/107327481201900206. [PubMed: 22487974].
86. Stephenson MB, Glaenzer B, Malamis A. Percutaneous Minimally Invasive Techniques in the Treatment of Spinal Metastases. Curr Treat Options Oncol. 2016;17(11):56. doi: 10.1007/s11864-016-0433-1. [PubMed: 27627999].
87. Hamad A, Vachtsevanos L, Cattell A, Ockendon M, Balain B. Minimally invasive spinal surgery for the management of symptomatic spinal metastasis. Br J Neurosurg. 2017;31(5):526-30. doi: 10.1080/02688697.2017.1297374. [PubMed: 28264589].
88. Bahouth SM, Yeboa DN, Ghia AJ, Tatsui CE, Alvarez- Breckenridge CA, Beckham TH, et al. Advances in the management of spinal metastases: what the radiologist needs to know. Br J Radiol. 2023;96(1141):20220267. doi: 10.1259/bjr.20220267. [PubMed: 35946551]. [PubMed Central: PMC10997009].
89. Bilsky MH, Laufer I, Fourney DR, Groff M, Schmidt MH, Varga PP, et al. Reliability analysis of the epidural spinal cord compression scale. J Neurosurg Spine. 2010;13(3):324-8. doi: 10.3171/2010.3.Spine09459. [PubMed: 20809724].
90. Hem S, Beltrame S, Rasmussen J, Vecchi E, Landriel F, Yampolsky C. Usefulness of minimally invasive spine surgery for the management of thoracolumbar spinal metastases. Surg Neurol Int. 2019;10(Suppl 1):S1-s11. doi: 10.4103/sni.sni_288_18. [PubMed: 31123635]. [PubMed Central: PMC6416751].
91. Kim YH, Kim J, Chang SY, Kim H, Chang BS. Treatment Strategy for Impending Instability in Spinal Metastases. Clin Orthop Surg. 2020;12(3):337-42. doi: 10.4055/cios20014. [PubMed: 32904056]. [PubMed Central: PMC7449857].
92. Manabe J, Kawaguchi N, Matsumoto S, Tanizawa T. Surgical treatment of bone metastasis: indications and outcomes. Int J Clin Oncol. 2005;10(2):103-11. doi: 10.1007/s10147-005-0478-9. [PubMed: 15864695].
93. Fujii Y, Yoshikawa R, Kashima R, Saho W, Onishi H, Matsumoto T, et al. Evaluation of Changes in Activities of Daily Living and Quality of Life of Patients with Bone Metastasis Who Underwent Conservative Therapy through Bone Metastasis Cancer Boards. Medicina (Kaunas). 2024;60(6):906. doi: 10.3390/medicina60060906. [PubMed: 38929523]. [PubMed Central: PMC11205938].
94. Pishnamaz M, Quack V, Herren C, Hildebrand F, Kobbe P. Treatment strategies for pathological fractures of the spine. Unfallchirurg. 2021;124(9):720-30. doi: 10.1007/s00113-021-01052-0. [PubMed: 34342665].
95. Kaloostian PE, Yurter A, Etame AB, Vrionis FD, Sciubba DM, Gokaslan ZL. Palliative strategies for the management of primary and metastatic spinal tumors. Cancer Control. 2014;21(2):140-3. doi: 10.1177/107327481402100206. [PubMed: 24667400].
96. Zakaria HM, Elibe E, Macki M, Smith R, Boyce-Fappiano D, Lee I, et al. Morphometrics predicts overall survival in patients with multiple myeloma spine metastasis: A retrospective cohort study. Surg Neurol Int. 2018;9:172. doi: 10.4103/sni.sni_383_17. [PubMed: 30210905]. [PubMed Central: PMC6122282].
97. Schoenfeld AJ, Losina E, Ferrone ML, Schwab JH, Chi JH, Blucher JA, et al. Ambulatory status after surgical and nonsurgical treatment for spinal metastasis. Cancer. 2019;125(15):2631-7. doi: 10.1002/cncr.32140. [PubMed: 30985913]. [PubMed Central: PMC6625859].
98. Barzilai O, Fisher CG, Bilsky MH. State of the Art Treatment of Spinal Metastatic Disease. Neurosurgery. 2018;82(6):757-69. doi: 10.1093/neuros/nyx567. [PubMed: 29481645].
99. Moussazadeh N, Laufer I, Yamada Y, Bilsky MH. Separation surgery for spinal metastases: effect of spinal radiosurgery on surgical treatment goals. Cancer Control. 2014;21(2):168-74. doi: 10.1177/107327481402100210. [PubMed: 24667404].
100. Aebi M. Spinal metastasis in the elderly. Eur Spine J. 2003;12 Suppl 2(Suppl 2):S202-13. doi: 10.1007/s00586-003-0609-9. [PubMed: 14505120]. [PubMed Central: PMC3591831].
| Files | ||
| Issue | Vol 12 No 3 (2026) | |
| Section | Research Articles | |
| Keywords | ||
| Minimally Invasive Surgery Metastases Kyphoplasty Vertebroplasty | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |


